论文信息 - Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States. - 字舞流文

Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States.

N. Joshi | V. Chirikov | L. Hashemi | D. Patel | N. Cornelio | I. Ma | Alden Smith | C. Giambrone | Alden R Smith